Rankings
▼
Calendar
IONS Q1 2022 Earnings — Ionis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
IONS
Ionis Pharmaceuticals, Inc.
$13B
Q1 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$142M
+27.2% YoY
Gross Profit
$138M
97.1% margin
Operating Income
-$58M
-40.5% margin
Net Income
-$65M
-45.9% margin
EPS (Diluted)
$-0.46
QoQ Revenue Growth
-67.7%
Cash Flow
Operating Cash Flow
-$32M
Free Cash Flow
-$35M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$2.5B
Total Liabilities
$1.8B
Stockholders' Equity
$710M
Cash & Equivalents
$543M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$142M
$112M
+27.2%
Gross Profit
$138M
$109M
+26.3%
Operating Income
-$58M
-$92M
+37.5%
Net Income
-$65M
-$90M
+27.5%
Revenue Segments
Commercial
$72M
25%
Research and Development Revenue
$70M
25%
Spinraza Royalties
$54M
19%
Collaborative Agreement Revenue
$50M
18%
Eplontersen Joint Development Revenue
$20M
7%
Licensing and Other Royalties
$12M
4%
Product
$6M
2%
← FY 2022
All Quarters
Q2 2022 →